(Q34090931)

30 July 2017

title

Prognostic Value of Volume-Based Metabolic Parameters Measured by (18)F-FDG PET/CT of Pancreatic Neuroendocrine Tumors (English)

1 reference

Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography

30 July 2017

main subject

1 reference

Ho Seong Kim

1

1 reference

30 July 2017

Joon Young Choi

2

1 reference

30 July 2017

Dong Wook Choi

3

1 reference

30 July 2017

Ho Yeong Lim

4

1 reference

30 July 2017

Joo Hee Lee

5

1 reference

30 July 2017

Sun Pyo Hong

6

1 reference

30 July 2017

Young Seok Cho

7

1 reference

30 July 2017

Kyung-Han Lee

8

1 reference

30 July 2017

Byung-Tae Kim

9

1 reference

30 July 2017

publication date

7 February 2014

1 reference

Nuclear medicine and molecular imaging NMMI

30 July 2017

published in

1 reference

30 July 2017

volume

48

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

180-186

1 reference

Prognostic Value of Metabolic Tumor Volume Measured by (18)F-FDG PET/CT in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated by Surgery

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145103

Prognostic value of volume-based (18)F-fluorodeoxyglucose PET/CT parameters in patients with clinically node-negative oral tongue squamous cell carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145103

Diagnostic value of (18)F-fluorodeoxyglucose positron emission tomography for pancreatic neuroendocrine tumors with reference to the World Health Organization classification.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145103

Prognostic significance of volume-based metabolic parameters in uterine cervical cancer determined using 18F-fluorodeoxyglucose positron emission tomography

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145103

High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145103

Neuroendocrine pancreatic tumors: guidelines for management and update

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145103

Baseline ¹⁸F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145103

Everolimus for advanced pancreatic neuroendocrine tumors.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145103

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145103

PET-CT in clinical oncology

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145103

Partial-volume effect in PET tumor imaging

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145103

A 5-decade analysis of 13,715 carcinoid tumors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145103

Whole-body FDG-PET imaging in the management of patients with cancer.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145103

Positron emission tomography imaging in oncology

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145103

Prognostic Significance of Volume-based Metabolic Parameters by (18)F-FDG PET/CT in Gallbladder Carcinoma

28 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13139-013-0262-0

Prognostic value of 18F-FDG PET/CT in patients with squamous cell carcinoma of the tonsil: comparisons of volume-based metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13139-013-0262-0

Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13139-013-0262-0

Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13139-013-0262-0

Prognostic Significance of Metabolic Tumor Volume Measured by (18)F-FDG PET/CT in Operable Primary Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13139-013-0262-0

18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13139-013-0262-0

[111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13139-013-0262-0

Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13139-013-0262-0

Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13139-013-0262-0

Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13139-013-0262-0

Clinical characteristics and malignant predictive factors of pancreatic neuroendocrine tumors

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145103

Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145103

Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization

28 October 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13139-013-0262-0

Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine tumors (PNETs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13139-013-0262-0

Evaluation of Response to Neoadjuvant Therapy by Quantitative 2-Deoxy-2-[F]Fluoro-D-Glucose with Positron Emission Tomography in Patients with Esophageal Cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25177374

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25177374

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13139-013-0262-0

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference